SNAP-8 vs argireline is a comparison of two closely related cosmetic peptides sold as topical “Botox alternatives.” Argireline has six amino acids and SNAP-8 has eight, and the maker claims SNAP-8 is the stronger of the two.[1][2] But argireline is the only one tested on its own in independent human trials, with mixed results, and no published study has compared the two directly in people.[5][7]

This comparison covers how each works, the evidence, side effects and legal status. For background, see our peptide basics hub and the SNAP-8 profile.

SNAP-8 vs argireline at a glance

ArgirelineSNAP-8
INCI nameAcetyl hexapeptide-8 (also acetyl hexapeptide-3)[8]Acetyl octapeptide-3[1]
Length6 amino acids[4]8 amino acids (argireline plus two)[2]
DeveloperLipotec (Spain)[4]Lipotec, now part of Lubrizol[1]
Claimed actionPartly blocks the nerve signal that tightens expression muscles[4]Same target, claimed to be stronger[3]
Independent human trialsSeveral randomized studies, mixed results[5][7]None on its own; only mixed-ingredient products[9]
Best headline result48.9% improved vs 0% on placebo in 60 adults[5]Company claim of 63% less maximum wrinkle depth[2]
StatusCosmetic ingredient[11]Cosmetic ingredient[11]

How argireline and SNAP-8 work

Skincare peptides are often grouped into four families: signal peptides, enzyme-inhibitor peptides, neurotransmitter-inhibitor peptides and carrier peptides.[12] Argireline and SNAP-8 belong to the neurotransmitter-inhibitor group.[3]

Both copy the tip of SNAP-25, a protein that nerve endings use to release the chemical signal that makes a muscle contract. The idea is that the peptide competes with SNAP-25 and makes the release machinery (the SNARE complex) less stable, so expression muscles relax slightly.[3][4] In lab tests, argireline reduced neurotransmitter release with a potency similar to botulinum toxin type A but a much smaller maximum effect.[4] For SNAP-8, manufacturer lab data cited in a 2020 review reported a 43% drop in glutamate release at 1.5 mM.[3]

The penetration problem

Both peptides have to cross the skin’s outer barrier to reach a nerve-muscle junction. A 2025 review concluded that argireline penetrates skin poorly because it is water-loving and relatively large. In one lab test it cited, about 0.22% of applied argireline entered the outer skin layer and none passed through.[8] SNAP-8 is bigger, with two more amino acids, so a longer chain does not obviously solve this.[2] This is the biggest unknown for both.

The evidence: argireline

Argireline has the longer research record, but results are mixed:

  • 2002, Spain: its developers reported that a 10% emulsion reduced wrinkle depth by up to 30% after 30 days in women volunteers.[4]
  • 2013, China: in a randomized, placebo-controlled trial of 60 adults with eye wrinkles, 48.9% improved with argireline vs 0% with placebo after 4 weeks.[5]
  • 2017, Greece: a 24-person randomized study supported an anti-wrinkle effect for argireline combined with another peptide.[6]
  • 2023, Indonesia: in a double-blind trial of 21 women with crow’s feet, a palmitoyl pentapeptide-4 cream looked better than an acetyl hexapeptide-3 cream and placebo after 8 weeks. The authors called it an initial study needing more participants.[13]
  • 2023, Germany: a double-blind, split-face study of 19 women found no significant difference between a serum with argireline and the same serum without it.[7]

The evidence: SNAP-8

SNAP-8’s case rests mostly on company data:

  • Lubrizol product page: “up to 72%” reduction in maximum wrinkle depth, with no study details.[1]
  • Lipotec feature (2016): a 63% reduction in maximum wrinkle depth after 28 days with a 10% SNAP-8 cream in women volunteers. Group size, controls and statistics were not described.[2]
  • Independent work: in a 2024 Korean study, 24 adults wore a dissolving microneedle patch containing acetyl octapeptide-3, a vitamin C derivative and another active under one eye, and a plain patch under the other. Wrinkles improved more on the active side, but SNAP-8’s own share can’t be separated.[9]

Side effects and safety

  • On the skin: argireline caused no irritation in its developers’ tests and no significant skin reactions in the 2023 German study.[4][7] No adverse effects were reported in the Korean SNAP-8 patch study.[9]
  • Injected: neither peptide has been studied as an injection. A 45-year-old woman injected with argireline in the forehead and temples developed nodules and abscesses from Mycobacterium abscessus and needed 5 months of antibiotics.[10]
  • Long-term use: there is little long-term data for either.

Both are cosmetic ingredients. Cosmetics do not need FDA approval before sale, but a product meant to change the structure or function of the body is legally a drug.[11] A 2025 review noted that a peptide that truly altered muscle function could stop qualifying as a cosmetic.[8] Neither peptide is FDA-approved to treat wrinkles.

Cost depends on the finished product rather than the peptide. The manufacturer recommends 3% to 10% of its SNAP-8 solution in a formula,[1] and labels rarely state how much of either peptide is inside. Our guide to peptide cream vs serum explains why the base formula also matters.

Which might suit you?

These are questions to raise with a dermatologist rather than a recommendation:

  • Do you want the most-studied option? Argireline has more independent data, though it is still thin.
  • Are your lines mainly from movement or from sun damage? Neurotransmitter-inhibitor peptides target expression lines; collagen-signaling peptides are a different approach. See Matrixyl vs argireline and GHK-Cu vs Matrixyl.
  • Do you need a proven result? Approved treatments such as botulinum toxin injections have far stronger evidence, along with their own risks.

The verdict

On paper, SNAP-8 is the longer, newer version of argireline. In practice, nobody has shown in a published human trial that it works better, or that either peptide reliably reaches the muscles it is meant to relax.[8] If you want to try one, argireline has more independent testing behind it. Expect modest results at best, and avoid injected versions.